Dr. Sergio Baranzini PhD Professor Professorship in Neurology I Heidrich Family and Friends Endowed Chair in Neurology Weill Institute for Neurosciences Department of Neurology, Graduate Program in Bioinformatics Institute for Human Genetics Institute for Computational Health Sciences University of California San Francisco San Francisco (CA) | USA
Sergio E. Baranzini is Distinguished Professor of Neurology I at the University of California San Francisco (UCSF). He is also a member of the Graduate Program in Bioinformatics, the Institute for Human Genetics, the Bakar Computational Health Sciences Institute, ImmunoX, and the California Institute for Quantitative Biology (QB3). He holds the Heidrich Friends and Family endowed chair in Neurology.
Dr. Baranzini earned his degrees in clinical biochemistry (1992) and PhD in human molecular genetics (1997) from the University of Buenos Aires, Argentina. Dr. Baranzini then moved to UCSF to specialize in the analysis of complex hereditary diseases, and focused his efforts on multiple sclerosis (MS). His lab uses a multi-disciplinary approach to science and it is composed by experimental and computational researchers. His current work involves the large throughput analysis of samples from MS patients to characterize the activity of genes during different stages of the disease, differential response to treatment, and disease progression. His lab also performs in-vitro and in-vivo immunological studies to understand the pathogenesis of MS. Dr. Baranzini leads the iMSMS, an international consortium to study the effect of bacterial populations (microbiota) on MS susceptibility and progression
In addition, Dr. Baranzini is the principal investigator of the SPOKE project, a large multi-disciplinary bioinformatics approach to gather, integrate and analyze all biomedical data, currently supported by NIH and NSF.
Dr. Baranzini has published his research on MS in several top-tier journals like Science, Nature, PNAS, J Immunol, and PLoS Biol. He is a member of the International Multiple Sclerosis Genetics Consortium, the American Association of Immunologists, and an elected member of the American Neurological Association and the International Society of Neuroimmunology. He is also a member of the Editorial Board of the MS Journal, Neurology and mSystems in addition to serving as an ad-hoc reviewer for several other scientific publications in including Nature Medicine, PNAS, and the Am J Hum Genet.